A retrospective study of COVID-19 vaccination and Guillain-Barre syndrome using the National Immunoglobulin Database
Latest Information Update: 01 Mar 2023
At a glance
- Drugs AZD 1222 (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 01 Mar 2023 New trial record
- 13 Feb 2023 Results published in the Brain